Dr. Elena Marchetti, MD
Chief Medical Officer & Medical Advisory Board Chair
Dr. Elena Marchetti is InterHealthTour's Chief Medical Officer and the primary author or medical reviewer of the majority of clinical content on this platform. She trained in medical oncology in Italy before working at the World Health Organization in Geneva on international health policy and cross-border patient safety standards. She holds direct editorial authority over clinical accuracy across the site and personally reviews every new partner clinic application.
Photo by Pavel Danilyuk / Pexels · illustrative, not a photo of the physician
Full Biography
Dr. Elena Marchetti is a board-certified oncologist and global health specialist who serves as Medical Director at InterHealthTour, overseeing clinical content standards and partner clinic verification across the platform. Prior to joining InterHealthTour, she worked as a global health specialist at the World Health Organization in Geneva, where her work focused on reviewing international patient safety standards across multiple countries' healthcare systems — experience that directly shapes her current emphasis on multidisciplinary case review and transparent outcomes reporting.
Her clinical background is in oncology, with particular attention to how treatment planning decisions are communicated to patients navigating complex, high-stakes decisions — often while managing significant emotional and financial pressure. This perspective informs her broader editorial philosophy across InterHealthTour's clinical content: that patients are best served by complete, honest information rather than reassurance alone.
Role at InterHealthTour
As Medical Director, Dr. Marchetti personally reviews complex oncology referrals before they are matched with partner centres, verifying that proposed treatment plans align with current international guidelines (NCCN, ESMO) for the specific cancer type and stage in question. Every clinical guide published on this platform passes through her review before publication, checking medical accuracy, appropriate risk disclosure, and alignment with current evidence — a process that regularly sends draft content back for revision when complication rates are understated or alternative treatments are not adequately presented.
Institutional Contributions
The annual re-certification requirement that removes any partner clinic failing to maintain valid JCI, NABH or equivalent accreditation was implemented under her clinical governance framework. She has also established the platform's policy requiring multidisciplinary tumour board review as a condition of continued partnership for any oncology-focused clinic in the network — a standard not universal even among internationally marketed cancer treatment centres.
Editorial Standards Applied
All content reviewed by Dr. Marchetti follows InterHealthTour's verification methodology: partner clinic accreditation is checked annually, clinical claims are cross-referenced against current international treatment guidelines, and every guide includes honest discussion of risks and alternatives rather than presenting a single recommended path as the only option. See our full verification methodology for details.
Approach to Clinical Content Review
Patients researching cancer treatment options abroad who read content reviewed by Dr. Marchetti benefit from a review process shaped directly by her time reviewing international patient safety standards at WHO Geneva. That experience taught her how significantly healthcare quality can vary even among facilities with superficially similar marketing claims, and how essential independent verification is for patients making decisions from a distance, often without the local knowledge to distinguish genuine excellence from confident presentation.
Her review process for oncology content specifically checks whether treatment protocols align with current international guidelines (NCCN, ESMO) for the relevant cancer type and stage, whether multidisciplinary tumour board review is described as standard practice at any recommended centre, and whether prognosis and risk information is presented with appropriate honesty rather than uniform optimism designed to encourage booking decisions.
Why This Matters for International Patients
Cancer treatment decisions made under geographic and emotional distance from familiar healthcare systems carry particular risk of being influenced by confident-sounding but unverified claims. Dr. Marchetti's institutional role — requiring annual re-accreditation verification for all partner clinics and multidisciplinary review as a condition of oncology partnership — exists specifically to reduce this risk, giving patients researching treatment through this platform a meaningfully higher verification standard than marketing claims alone would provide.
Independent Verification
Readers are encouraged to independently verify current credentials rather than relying solely on this summary. Registration and standing can be checked directly with the relevant national medical board in her jurisdiction of practice, and professional affiliation confirmed through World Health Organization (publicly searchable at who.int). Additional verification is possible through WHO's public staff and consultant directories for the relevant period, alongside her published contributions to international patient safety literature. InterHealthTour reviews these credentials periodically as part of our ongoing partner verification process, but we encourage patients to conduct their own independent check before making treatment decisions based on any specialist's involvement with content on this platform.